Effect of Consumption of Non Caloric Sweeteners and Insulin Sensibility

Instituto de Nutrición y Tecnología de los Alimentos

Status: Unknown

Conditions: Insulin Sensitivity

Treatments: Dietary Supplement: Artificially sweetened beverages; Dietary Supplement: Sugar sweetened beverages

Study type: Interventional

Funder types: Other

Identifiers

NCT02890108

EANC-1

Details and patient eligibility

About

This study will compare the effect of acute consumption of two carbonated drinks, sweetened with sugar or with non-caloric sweeteners, over the insulin response of healthy adults who normally consumed foods or drinks that contain non-caloric sweeteners

Full description

During the last decades there has been a sustained increase in prevalence of overweight and obesity and, along with it, of chronic noncommunicable diseases. There have been addressed various management strategies, including sugar replacement for Non-caloric Artificial Sweeteners (NAS). Nevertheless, in several cohort studies it has found the opposite effect, it has observed associations between the consumption of NAS with greater weight gain and increased risk of type 2 diabetes and metabolic syndrome. In clinical trials, in both humans and mice, there has been greater association with glucose intolerance, being 3 possible mechanisms: 1) dysbiosis of the intestinal microbiota; 2) altered regulation of appetite cephalic phase and secretion of glucagon like peptide-1 (GLP-1); and 3) increased intestinal glucose absorption via increased Sodium-Glucose Linked Transporter-1 (SGLT-1) and Glucose transporter 2 (GLUT2), transporters to glucose absorption.

In the following review the major findings in the literature regarding the consumption of NAS and its deleterious effects on human health will be studied.

Enrollment: 10 estimated patients

Sex: All

Ages: 25 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Body Mass Index (BMI) between 18,5 - 24,9 kg/mt2
• Healthy men or women
• Fasting plasma glucose < 100 mg/dL

Exclusion criteria

• Consumption of drugs affecting glucose metabolism, antihypertensives or lipid lowering
• Subjects with insulin resistance, type 1 or 2 diabetes, dyslipidemia, hypertension; heart, liver or kidney disease, respiratory failure, stroke, or any chronic illness.
• Pregnant women.
• Being treated to gain or lose weight.
• History of recurrent episodes of acute diarrhea.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind

---

10 participants in 2 patient groups

Sugar sweetened beverages

Experimental group

Description:

Subjects will receive, in 3 different ocassions, 350cc (1 can) of a sugar sweetened beverage, that contain 38,7 grams of carbs and 154 kcal, separated by at least 1 week each one

Treatment:

Dietary Supplement: Sugar sweetened beverages

Artificially sweetened beverage

Experimental group

Description:

Subjects will receive, in 3 different ocassions, 350cc (1 can) of a artificially sweetened beverage, that contain 84 mg of Aspartame, 56 mg of Acesulfame K and 0,7 kcal, separated by at least 1 week each one

Treatment:

Dietary Supplement: Artificially sweetened beverages